Professional Documents
Culture Documents
ABSTRACT
Objective: To compflre dissolution 1C.I7I/tS for cOllllllcn-ial formulations in USP Apparatus 2 /Ising t:ollvcntio71({/ uSP vessels
(lnd PEAKl'M vesse/s. Methods: Disso/utio71 stllt/ies flsing C07J/mcrt:ially available disintegrating fablets of f1cctfl'llli110pbcn
and l1aproxcl1 sodiu'IJI were conducted in USP Apparatus 2
/lsillg usp /I"d PEAK'" vessels. The effict of)onl" diJjerent
RPMs (25, SO, 7S/lnd 100) find tl,,-ee dissolutiollllledifl
('Vflte>; J % 1ivem 80 fllld pbospb/lte bliJjel; pH 5.8 ""d 7.4
fin-
INTRODUCTION
of t he problems
associate d with us p
Apparatus 2 is the forma
tion of a cone of material at
the bottom of the dissolution
vessel. Dosage forms, es peciall y
o n es with dense excipie nts,
tend to form a cone at the bottom of the vessel giving rise to
an unstirred regio n of drug
ma terial. T his redu ces the su rface a rea of th e disso lvin g
material in co ntact with th e
dosage fOfm and consequently
affects t he di sso lution rate.
Cone form atio n co uld be a
probl e m predomina ntl y with
Apparatus 2, but ma y also hap.
pen in Apparatus I if the parti
c1es are released From th e wire
mesh ba sket. Ea rli er studi es
have established the inAuence
of the geometry of the dissolu
ne
Ti",. ,min)
(Me. . .l ~. I) . . . -(; )
"
'"
00.
...::.4".....
1581 I IJ
4474.l S4
JOIS!202
"
"
W
4618.t2&4
~5
~11tlI i 2.9.1
'"
~~ ~I
19
~6
2.44
9~6
'N4JJ
9~
12< 448
, 1 fK>
l~WIJ81
8187iO~
00
'nO?
Q497~ O~M
"
'nI8~OJ7
9713-,- 141
IOO.D
84~J 11.9~
81.57 ~ 1.1'"
20
"
....
I 18
oi
0 ~8
00
%74 t 1.21
%911. 1.25
"
100.49 t 0.61
10041 -'-
96.28.t 0.61
9(,.21
00
9983! 0.47
'!'Jill 10.%
1.
O~~
0.77
"
"
11m. , .. iD)
'00
l'SP
n :AJ(I"
10.8.-10 21
9.58", 2.S
00
B)2! 7.5
)5.84 3.34
,."
"
SS 6 11.1.31
55.77.1. 4 46
728ItI O.97
11.1 1 I, D)
'",
..
"
"
% N..... H<1
8J.4! ~ 4IH
92.18.l. 1061
19 12:t 8.)6
32.87 2.39
5UJi 15.06
74.611
97.89 1M
17.24
"
"
",
81U9.l. )49}
00
I/J227.62
US I
",
"
"
876629.22
28.lJ.i. 1.55
472JS.19
~.72 i
0.2 5
93) i 9.111
%(I4 t 69)
24 sa 10 5.38
65.29
2.00
10.1
88.52 10 2.22
8768 t 7.93
101.061. U4
Dissolllrioll7i:dJllologieslNlAY 1998
METHODOLOGY
Dissolution studics on commerciall y available disintegrating tablets of acetamino ph en
and naproxen sodium were
co ndu cted in US P Apparatus 2
using US P a nd PEAKTM vesse ls.
Dissolu tio n was performed at
four different speeds: 25, 50, 75
and I 00 ~P,\I. Three dissolution
media [phosp hate buffer (p i I
5.8 and 7.4 for "cetaminophen
and naproxen sodium respectively), water, and 1% l\veen
80[ were used in t he study. Both
n ondeaerated and deacrated
media we re used to investigate
the influence of presence at air
on the dissolution profi le.
Deaer~ltion was ac hi eved by
so ni c<ltin g the di sso luti o n
medium for 20 minutes. The
temperature of t he dissolution
m edium was maintained at
37(0.05)C. Dissolution of
acetami nop h e n a nd naproxen
sodium tablets we re also condu cted in USI' Apparatus I at 50
RP ,\1 us ing phosphate buffer as
the disso lu tio n media with both
the vcsse ls. All a nal yses were
performed by UV spectrophotomctry. Thc detection wavele ngth var ied with the drug:
2B nl11 for acetam ino phe n and
332 nm for naproxen. St<l ndard
curves were lin ca r with r! values
;"0.999. Sig nifi ca nt differences
in perce nt dissolution we re car ried o ut usin g a two-tailed ttest performcd in A1icr050ft
Excel softwa re, Ver 5.0.
RESULTS AND
DISCUSSION
I. Effect of RI'M 011 tbe mix;ug
dYllo'lIIics ill the two vessels:
There was more than a twOfold increase in the di ssolutio n
rate of acetaminophen in the
PEAKTM vesse ls co mpared to the
Time
(mill)
2. Effect of dissolutio"
1lledin:
Acetaminophen
disintegrating tablets
As seen in Table ill, a
slllali difference of abou t
4 % was seen in the first 5
111111
In the p erce nt
release
of
acetamin o ph en w hen the dissolution was performed
in phospha te buffer 1'1-1
5.8. Wh en th e dissolutio n media was rep la ced
by water this difference
in c reased to 10% wi th
t he PEAKTM vesse ls showin g hi g h er dissolution
rate. The hi gher solubil ity of acetaminophen in
T\veen 80 resulted in no
observed
differ e nce
be twee n the two vesse ls.
"
"
"
Wnler
1% T""fU 110
IISP
PEA ".....
US,
PEAK''''
US,
O'EAK'"
75.39'" 3.8J
91.4 :1:3. 15
9S.JS:I: 3.68
97.65:1: 1.16
93.01'" 1.18
100.17:1:0.28
l00.5!5
O.l~1I
Time
1% T .."t u 80
10
usr
1'f:AJ('"
usr
.... K""
usr
19.1l s 1.36
It.7'''B.t
rF..AK'''
4 9.''''~.5
n.72"' .18
"'5J "'I."
$1.5,)", 15.011
71 .7 1 *1.54
,Ut. 10.7
9l.7"'H
75.811 ....1
75.2"'2.56
l OU I.1
9<4..1' '''J.I.I
".5 .. .1.76
~r
15
74.68"' 17.14
97.19 1.'5
'l.II ~ . 4
10
1IIL~"
".n. US
101.'''2.0
14.'l
".""'h7
Tim.
(m in )
Naproxen
sodium tablets
Diffe re n ces in mi x in g
pro fil e were seen fo r a ll
dissolution media in t he
case o f na proxen sod ium
tablets
Cfa bl e
IV).
Approximately 50% of
the drug was re leased in the
PEAKI'M vesse l within the initial
5 minutes co mp a red to only
30 % re le<1se in th e USP vesse l
with water as th e dissolution
m ed ium. A sig nifi ca nt difference (1'<0.05) was o bserved for
the Tween 80 so luti o n only
durin g th e initi a l S minutes.
This is because the su rfa cta nt
redu ces th e interfacial te nsion
betwee n th e so lid co ne a nd the
surroundin g med ia in the US P
vessel a nd narrows th e differe nces in release rate between
,
"
"
"
"
Apptlnolu.2
"ppIOra lus I
Us.
'''K"'
US,
I'r.... "....
8 1.87'" 0.86
78.39:1: 6.57
93.01'" 1.18
94.91:1: 0.58
9ZA~ :I:
4.504
91.111 0.37
97.33'" U J
%.69 3.42
100.14:1: 0.44
100.21., O.R
100.6H:I: 0.71
3. Testing Devices
Apparatus 1 and Apparatus 2
\"'h e n pe rfo rmin g the dissolution of ace taminoph e n in Apparatu s 2 at 50 RPM, a sig nifi ca nt
difference (I' < 0.05) in mixing
was o bse rved in th e initial 10
minutes. H owever, in Appararus 1 there wa s no sig njfi cant
difference (L1ble V). L1 the case
DissollltionTeclmologiesllvlAY 1998
Ti", ..
50 NPM
s.n., ....,
(_I.)
,", ppars'". I
USP
10.49,", l.6.J
1!!.99 cO. ]
"'"
PF.... "-
I '-II,", LJ6
J1.87 2..19
"
18.77'" 5.66
45.0 1 .t 6.95
5 1.53:i 1S-1Mi
72.7. :l1.5ot
"
60.811
60.72
74.611 17.14
97.119
"
"
'"
76-17" 9..!17
n ..I.H . IOJ
88..59 14.93
99.72:l: o.:S
89.3.t 9.'4
87.19.t !f.4'
93.3,* 9.83
% .... 9.7
'Hi."":l 6.9 1
oj
7.'1
U4
j,
of<
1.65
,,,,i,, )
N. I<.~
15 KPlI1
,
"
"
"
"
,
"
"
"
..
1 )ft~"ltd
"'"""o.d-.....'...
1.44
S,II" """)
"F..... "....
1ka<,,'nI
~ ."A.5.~
\1.56
U.14 Il 4.18
'#!I.JIIl 4.48
'Hi"" s l.'!
19.~ 1
JO. 15A.l.01
~5.80"'UI
1~U4 1l
5S.91
ok
44.'4
...........
61.1151l 7.19
SU8sl.'U
116.111 t 8.7J
55.51
3.M
75..l\11l JM
15.12'" 5.11
lllAl ",0.16
,...,.,. s 0.58
3'.~.t 1.~4
It
5.",
Noad.Ht"II,ed
5."
15.81 :l 1,13
5OII.PM
". IM s 0037
".ll'" 1.4J
100.5.1 s 11.811
Tlble VIII. Diuol ulioo d i ll ,,( naprU f n sodi um ill US I' Apparalull using us r a nd
I.:A .........tllub u.,ing nond uc r. lw and deae r. ted Ilhosphlli t bufftr (pll 7.4).
~;.....""
_ 1M... _ S.D~-;'
Nc.ocItM,, ' nI
lICIlI~M
"
"
"
""
I.."
I~ .a~ ~.'4
I.5t
O...... ,nI
".14.'"
51..SJ.t 15.11>
Q.1Mo.t
7U'.17.z.4
...59. IoU}
il.lZ.'.l1
97....
... 71 .... l5
7..... IZA5
9!.1J .....
'I6.IJ J. 4.SII
1UI.SJI
t.J.1. 7.6:
UH*4.Jl
oUAJ. 4..57
","~.l.H
~}
17.'J l.as
17.... '.1
1JU1.
ll..lIl. 1.10
101.17. 0.68
.U5 .. 7.-"1
.w. '.aJ
I~
M.}. !.54
~II~ I
"
"
'"
"
' '''111'1>1
"
"
"
.. 7."
'.1Mi
If ..... O...
".15,. (.48
Jl.Jj .. 7.55
1...... 5.lS
I>!.lt.l 10.1
"'-67.
87.~
.. J.tJ
911.01* l. ..
6.!2
".111"
47.LI.5.I'
oft.'} oJ.J1
III.!J .. l.ll
U1J. U16
10 1.116 ..
I.J~
".JJ Il .. I
0.711
4. ["fiuellce of N01ldellerIltiolllDeneration
There was a signjfic;ult differe nce (1'<0.05) in the
amount of acetaminophen
rel eased in the nondeaerated/deaer ated m edia in
both USP and PEAKTM vesse ls (Ta ble Vll ). T he
amou nt of dr ug released
was hi gher in the nondeaerared
media compared to the deaerated m ed ia in both the vessels.
There was also a significa nt difference in the re lease profile of
acetaminophen in the two vessels in nondeaeratcd med ia.
CONCLUSIONS
The PEAKTM vessels eliminate
the formation of a cone of material s in Apparatus 2 ofte n
observed with certa in kinds of
dosage form s. T his was evident
from visua l observation of the
vessel during dissolution study
and also from the dissolution
resu lts. T h e PEAKnl vesse ls
showed a higher release rate
wi th both the co mm ercia ll y
ava ilab le disintegra tin g tablets
empl oyed in this snldy. Contrary to previous studies, the
results fro m th is study indicated
that stirring speed and the presence of air can influ ence the
amo unt of drug released in bodl
vessels. PEAKTM vessels, however,
provide an effect ive way to
improve the mixing hydrodynami cs in the dissolution vessel
and reduce the variabi lity typicall y observed for conventional
USP vessels.
SI'I: Referen ces .. .continue,! flext page
Solax Awards
""'m,"
rt'Spec1I...:!
research
Dr,.
enIJft mselW"l1 proje\:lS (k,'S@e(! 10 r""' nt~'\ proWC! (jUaI ity m..,,'4:
drug devollop"!.'111 and Mli)alion, ,I,bou1 .140 'c..-esenI.Ptives from
FO.t.. ac:adcmoa and ,nc1Jstry pao-tJcJp1(e(I In !he meeIIr(. The ' .goF<lU$ (kswssions and Sl@eS~Offi !Jot the p.atltiP1Y'ts resulCd nine
I(;fr!1(liu1l0n of ~~a \X:jCctrCS if1\1rcs.eam .. Ojects l or POR I
PQRI prc!(x:ts ...1be pet'forn...'tlln aWcr~ 01 COInir(
~ ... the speafoc.JlJDr1ll!Q<.O' cmen\lI 11 testiI'C pUle...
d\lCS to< Ilf(I(klct qua'il)t. ~ is 1'I<l(le(i (hal the li1armao:ewca1 ilOOfr
tly I'M b<-.;)fit IrO'll SOlllO cIliw\:C In the 'eguiiltory proooss in 11K!
form 01 .tIOI'lero~ lite aug awilC81ion prDCeSS IlOO" focilit8l1ll! !he
3f11l1OWi process MIfIi1 FI)I.. Some 01 the p-(Ij(lets bef1i consi<le<ed
'.,.I.,to areas of drug SObst......... , glUC: prO<1Jcts, biopI>iJmH""lII>cs
and sdero::e mlr1 ageort'rlt , ~ is 1Il1ltip.al;:ed thai the research projeds OOl.id be I\Jnded by grants from 1i1;Y~ cornp/!I1"" 0/
01Il(!f SOU!CeS. Two Iihllfl\'\b:)!:utio:;aI ooo'~Oes h<Ne pledged filllJ:\
Cl~ 1 i uP;lCt\ for tile f.()l,ti'lk1l:k:<1 011M l"\\ects ,
MJ'S is ..ork", LO coI~dl.1>O WIth fD/\ to !onnaIim m m<lIlage PQRI.lhe roles lot MPS Illhis ioitoMM!l irdOOc: pnMdire sci-
ald ~
,,,J
:H'e,,( in'""", . Co nc".! 1' '' ''c''(i ~'''''.'' i" ", ,h" ~ll.l
,r"",ti<MtI,,,,IiI)l'.'~'" ....1 ''''~bti<M' ,of the 101 1>rOC'edu", il",lf " ,II ~I>" he (\H,,,,kmlfur d", .w:lnl
'''''.I
I <I Pri..,
} '" I ,. m.e
Jrd 1'",<
IlI1CtKms fo' "ORI: c1spcrs l1g PQR I fW"lds: orgarw,i'll AAPS WO<1!.
shops to discuss 'MIlliS oIlhc research p!OjeclS in! a:Ol\Ie)'i'lg
!he ,erulLng A)COm!lll!l1daions to RlA: ald. !XI(lI"d!oOO,. PQR~relal
Kdc"''''"e',.
'""<I'"
1. I).
\\'
v,.
3. \\ . J..~","h , I'......
Ilc"",""c. I). '\1. IIo .. r"y un,1 \.
t< . l.~". A '<JflLI "' ''' 'j,'c """ )' "f
1'.1'/6.
."It";",,
"1'1"'""""']' I'b",."..
I'b",.",.-.I, H: I !+, 11.1 (I
'~ I) ,
(I'n!) ,
If,..,,,,
of ,b
in ,~I ""' ..... 'n'"
f,," n th>! or . 'phe", , ]. !'bum'
..../ 71(4): N.' -W) (I'J~21
We gra,d,tll )'
.dnn,,' le.jj:~
.[ S. ',....1' .",1A.
t: " LI\~. S~"'e",,,ie em,r:mo~iol ..~1 "'i( h '\1'1 "' '''''''' 1 "I' ,I",
I,,,,,
Il.
FI"t"~,,,
d"l "
"" "l{
on
fra,,,,,,
H ,t~IHI
)000 \" M
ed tranirt.
Other p.artO:Lpatir\t orgm Liatioos 10 PQRl lo:::We PharrnoccutrCIII
Res(oan;h ana Manu1ar::turetS 01 America (1'IlRMA). Generic Pharma
ceu\ocaIlnr:lUstry J.swQat..... (G'IA). Natrona! A,S!;ocial(/O 01 Ph3r
maceUliCIII ~Ioctu rcrs (N.O.PM). P... emert, 1Drug Associa!ion
II'DAJ. Nooprosc'f(Oon Drug Manul1ICturers AsSOC;atLOo(NDMA.)
and Natrona! PhaornacEUtk;:al AtliM(:e (t.l'lI.j.
REfERENCES
,nll"'",,,,'1' ill
I')L"II! ,Old ,,, tlcor k 'h" ,)(.~"si<M'. " h:t! ,h;,]eol,o ><.1
"I' on ."...... ~ ... ..,;.,,,,,,,. ;n ,I", r",kl ofbr'1,luml:l'
""u,i,",. '111~ ,,,,,, ,,1 willi", din...;,,,1
ric,,..
' ''''' w l ~' "r" i""o l,,,1 in ll"',",,",,'~"ti.,,,, L ~ '''~ Ih.
Il,,,. - ,hrou~h 'rSlm~ The 5l;"n"oc _I n;duucli
,,,,,.,."~':l(i' ~, u"y he prc"OU''''''LfI) r,,,,,,,,",1 un
,,,,di,,, m "<.",,,i,,<[ di ffer"nL'ypes "I' H"" 11"'"'1"'
""lis .oJ J."",~'C funn< (e.n. ''''''IC.n.'e .",1 n>n-
"r Ih~